Skip to main content
Top
Published in: Endocrine 2/2023

20-10-2022 | Magnetic Resonance Imaging | Brief report

Association between pituitary height and growth response to recombinant human growth hormone in prepubertal children with growth hormone deficiency

Authors: Zhixin Zhang, Xiaomeng Zhang, Wenquan Niu, Yuan Yuan

Published in: Endocrine | Issue 2/2023

Login to get access

Excerpt

Growth hormone deficiency (GHD), an important cause of short stature in pediatrics, can lead to a series of adverse consequences impacting normal growth and life quality [1], although its prevalence is relatively low (about 1 in 4000 children worldwide) [2]. The occurrence of GHD is intimately linked with insufficient secretion of growth hormone (GH) from pituitary [3]. …
Appendix
Available only for authorised users
Literature
6.
go back to reference V. Pampanini, S. Pedicelli, J. Gubinelli, G. Scire, M. Cappa, B. Boscherini, S. Cianfarani, Brain magnetic resonance imaging as first-line investigation for growth hormone deficiency diagnosis in early childhood. Horm. Res Paediatr. 84(5), 323–330 (2015). https://doi.org/10.1159/000439590CrossRef V. Pampanini, S. Pedicelli, J. Gubinelli, G. Scire, M. Cappa, B. Boscherini, S. Cianfarani, Brain magnetic resonance imaging as first-line investigation for growth hormone deficiency diagnosis in early childhood. Horm. Res Paediatr. 84(5), 323–330 (2015). https://​doi.​org/​10.​1159/​000439590CrossRef
9.
11.
go back to reference J. Schmitt, P. Thornton, A.N. Shah, A. Rahman, E. Kubota, P. Rizzuto, A. Gupta, S. Orsdemir, P.B. Kaplowitz, Brain MRIs may be of low value in most children diagnosed with isolated growth hormone deficiency. J. Pediatr. Endocrinol. Metab. 34(3), 333–340 (2021). https://doi.org/10.1515/jpem-2020-0579CrossRef J. Schmitt, P. Thornton, A.N. Shah, A. Rahman, E. Kubota, P. Rizzuto, A. Gupta, S. Orsdemir, P.B. Kaplowitz, Brain MRIs may be of low value in most children diagnosed with isolated growth hormone deficiency. J. Pediatr. Endocrinol. Metab. 34(3), 333–340 (2021). https://​doi.​org/​10.​1515/​jpem-2020-0579CrossRef
13.
go back to reference H. Li, C.Y. Ji, X.N. Zong, Y.Q. Zhang, Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years. Zhonghua Er Ke Za Zhi 47(7), 487–492 (2009) H. Li, C.Y. Ji, X.N. Zong, Y.Q. Zhang, Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years. Zhonghua Er Ke Za Zhi 47(7), 487–492 (2009)
14.
go back to reference Growth Hormone Research, S.: Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metab 85(11), 3990–3993 (2000). https://doi.org/10.1210/jcem.85.11.6984 Growth Hormone Research, S.: Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metab 85(11), 3990–3993 (2000). https://​doi.​org/​10.​1210/​jcem.​85.​11.​6984
16.
go back to reference H. Sharma, N. Purwar, A. Kumar, R. Sahlot, U. Garg, B. Sharma, S.K. Mathur, Pituitary hypoplasia is the best MRI predictor of the severity and type of growth hormone deficiency in children with congenital growth hormone deficiency. J. Pediatr. Endocrinol. Metab. 34(7), 851–858 (2021). https://doi.org/10.1515/jpem-2021-0049CrossRef H. Sharma, N. Purwar, A. Kumar, R. Sahlot, U. Garg, B. Sharma, S.K. Mathur, Pituitary hypoplasia is the best MRI predictor of the severity and type of growth hormone deficiency in children with congenital growth hormone deficiency. J. Pediatr. Endocrinol. Metab. 34(7), 851–858 (2021). https://​doi.​org/​10.​1515/​jpem-2021-0049CrossRef
18.
go back to reference D. Zenaty, C. Garel, C. Limoni, P. Czernichow, J. Leger, Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency. Clin. Endocrinol. (Oxf.) 58(5), 647–652 (2003)CrossRef D. Zenaty, C. Garel, C. Limoni, P. Czernichow, J. Leger, Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency. Clin. Endocrinol. (Oxf.) 58(5), 647–652 (2003)CrossRef
19.
go back to reference R. Coutant, S. Rouleau, F. Despert, N. Magontier, D. Loisel, J.M. Limal, Growth and adult height in GH-treated children with nonacquired GH deficiency and idiopathic short stature: the influence of pituitary magnetic resonance imaging findings. J. Clin. Endocrinol. Metab. 86(10), 4649–4654 (2001). https://doi.org/10.1210/jcem.86.10.7962CrossRef R. Coutant, S. Rouleau, F. Despert, N. Magontier, D. Loisel, J.M. Limal, Growth and adult height in GH-treated children with nonacquired GH deficiency and idiopathic short stature: the influence of pituitary magnetic resonance imaging findings. J. Clin. Endocrinol. Metab. 86(10), 4649–4654 (2001). https://​doi.​org/​10.​1210/​jcem.​86.​10.​7962CrossRef
Metadata
Title
Association between pituitary height and growth response to recombinant human growth hormone in prepubertal children with growth hormone deficiency
Authors
Zhixin Zhang
Xiaomeng Zhang
Wenquan Niu
Yuan Yuan
Publication date
20-10-2022
Publisher
Springer US
Published in
Endocrine / Issue 2/2023
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-022-03217-2

Other articles of this Issue 2/2023

Endocrine 2/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.